Associations between single-nucleotide polymorphisms of the VEGF gene and long-term prognosis of oral squamous cell carcinoma

被引:22
作者
Kaemmerer, P. W. [1 ,2 ,3 ]
Koch, F. P. [2 ]
Schiegnitz, E. [2 ]
Kumar, V. V. [2 ,3 ]
Berres, M. [4 ]
Toyoshima, T. [5 ]
Al-Nawas, B. [2 ]
Brieger, J. [6 ]
机构
[1] Harvard Univ, Sch Med, Boston, MA USA
[2] Univ Med Ctr, Dept Oral Maxillofacial & Plast Surg, D-55131 Mainz, Germany
[3] MR Ambedkar Dent Coll & Hosp, Bangalore, Karnataka, India
[4] Univ Med Ctr, IMBEI, D-55131 Mainz, Germany
[5] Kyushu Univ, Dept Oral & Maxillofacial Surg, Fukuoka 812, Japan
[6] Johannes Gutenberg Univ Mainz, Dept Otorhinolaryngol, D-55122 Mainz, Germany
关键词
advanced; long-term; oral squamous cell carcinoma; prognosis; single-nucleotide polymorphisms; smoking; VEGF; ENDOTHELIAL-GROWTH-FACTOR; ADVANCED BREAST-CANCER; FACTOR EXPRESSION; C/T POLYMORPHISM; RISK; SURVIVAL; BEVACIZUMAB; NICOTINE; PATHWAY; MARKERS;
D O I
10.1111/jop.12026
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Introduction Functional polymorphisms (SNPs) of the vascular endothelial growth factor (VEGF) are associated with the incidence of oral squamous cell carcinoma (OSCC). An impact of VEGF-SNPs on prognosis of OSCC patients seems possible. Therefore, correlations between prognostic parameters of OSCC patients and five VEGF-SNPs were determined. Materials and Methods In a retrospective long-term study, in 113 OSCC patients that underwent curative resections, five VEGF-SNPs (1154G/A, +405G/C, +936 C/T, 2578 C/A, and 460 C/T) were analyzed. Associations between SNPs and prognosis (incidence of local recurrent disease, second cancer, metastases, death, total disease-free survival) were examined. Results After a mean follow-up time of 57.6months, 32 patients had local recurrences; 15 patients had second cancer, 15 patients metastases, and 23 patients died. The mean disease-free survival was 43.1months. A significant increased incidence of OSCC in smokers with the VEGF 2578 A/C and 460 C/T SNP was seen (each P<0.0001). In univariate analysis, patients with advanced OSCCs (T>2 or N>0) together with the 1154 A/A allele had a significant worse survival and a worse disease-free survival (both P<0.04). The same was seen for the +405G/G SNP (both P=0.002). In multivariate analysis, only the negative influence of the +405G/G SNP on survival in advanced OSCCs (T>2) could be confirmed (P=0.002). Discussion Possible reciprocal interactions between smoking and VEGF-SNP function were observed. Multivariate analysis confirmed the VEGF +405G/G genotype to be associated with poor survival in advanced OSCCs; a further use of this haplotype as biomarker has to be discussed.
引用
收藏
页码:374 / 381
页数:8
相关论文
共 55 条
  • [11] Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin's lymphoma
    Diao, Lan-Ping
    Yu, Xiao-Ming
    Gao, Yu-Huan
    Li, Yan
    Liu, Hai-Sheng
    Liu, Li-Hong
    Zhou, Rong-Miao
    Wang, Na
    Wu, Li-Li
    Wang, Shi-Jie
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (11) : 1473 - 1481
  • [12] Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: A systematic review
    Diaz-Padilla, Ivan
    Amir, Eitan
    Marsh, Sharon
    Liu, Geoffrey
    Mackay, Helen
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 124 (02) : 354 - 365
  • [13] Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: Correlation with treatment response and survival
    Dudek, AZ
    Mahaseth, H
    [J]. CANCER INVESTIGATION, 2005, 23 (03) : 193 - 200
  • [14] Vascular endothelial growth factor 936 C/T polymorphism in cancer patients
    Eroglu, A.
    Gulec, S.
    Kurtman, C.
    Cam, R.
    Akar, N.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (09) : 1467 - U4
  • [15] STUDIES ON THE ABILITY OF SMOKE FROM DIFFERENT TYPES OF CIGARETTES TO INDUCE DNA SINGLE-STRAND BREAKS IN CULTURED HUMAN-CELLS
    FIELDING, S
    SHORT, C
    DAVIES, K
    WALD, N
    BRIDGES, BA
    WATERS, R
    [J]. MUTATION RESEARCH, 1989, 214 (01): : 147 - 151
  • [16] Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
    Gasparini, G
    Toi, M
    Gion, M
    Verderio, P
    Dittadi, R
    Hanatani, M
    Matsubara, I
    Vinante, O
    Bonoldi, E
    Boracchi, P
    Gatti, C
    Suzuki, H
    Tominaga, T
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (02) : 139 - 147
  • [17] The importance of-460 C/T and+405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer
    Hansen, Torben F.
    Spindler, Karen-Lise G.
    Lorentzen, Karen A.
    Olsen, Dorte A.
    Andersen, Rikke F.
    Lindebjerg, Jan
    Brandslund, Ivan
    Jakobsen, Anders
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (05) : 751 - 758
  • [18] VEGF polymorphisms and survival in early-stage non-small-cell lung cancer
    Heist, Rebecca Suk
    Zhai, Rihong
    Liu, Geoffrey
    Zhou, Wei
    Lin, Xihong
    Su, Li
    Asomaning, Kofi
    Lynch, Thomas J.
    Wain, John C.
    Christiani, David C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) : 856 - 862
  • [19] Polymorphism of vascular endothelial growth factor-1154G&gt;A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies
    Hong, Ting-Ting
    Zhang, Ru-Xia
    Wu, Xiao-Hong
    Hua, Dong
    [J]. MOLECULAR BIOLOGY REPORTS, 2012, 39 (05) : 5283 - 5289
  • [20] Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma
    Howell, WM
    Bateman, A
    Turner, SJ
    Collins, A
    Theaker, JM
    [J]. GENES AND IMMUNITY, 2002, 3 (04) : 229 - 232